ALK and anaplastic large cell lymphoma: ORR 44% with CRR 19% after 4 cycles. ORR and CRR 100% and 50% in ALK- ALCL, 100% and 100% in MF.Median time to progression and next therapy 4.5 and 5.0 monthsNo correlation between correlative PD-1 levels and response.